TY - JOUR
T1 - Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment
AU - Kaur, Navdeep
AU - Fang, Yao Ching
AU - Lee, Hsueh Yun
AU - Singh, Arshdeep
AU - Nepali, Kunal
AU - Lin, Mei Hsiang
AU - Yeh, Teng Kuang
AU - Lai, Mei Jung
AU - Chan, Lung
AU - Tu, Yong Kwang
AU - Banerjee, Suddhasatwa
AU - Hu, Chaur Jong
AU - Liou, Jing Ping
N1 - Publisher Copyright:
© 2019
PY - 2020/2/1
Y1 - 2020/2/1
N2 - A series of 10,11-dihydro-5H-dibenzo [b,f]azepine hydroxamates (4–15) were synthesized, behaving as histone deacetylase inhibitors, and examined for their influence on vascular cognitive impairment (VCI), which correlated with dementia. The results revealed that (E)-3-(4-(((3-(3-chloro-10,11-dihydro-5H-dibenzo [b,f]azepin-5-yl)propyl)amino)methyl)phenyl)-N-hydroxy-acrylamide (13) increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy in in vivo study. It is also able to increase the level of histone acetylation (H3K14 or H4K5) in the cortex and hippocampus of chronic cerebral hypoperfusion (CCH) mice; as a result, it could be a potential HDAC inhibitor for the treatment of vascular cognitive impairment.
AB - A series of 10,11-dihydro-5H-dibenzo [b,f]azepine hydroxamates (4–15) were synthesized, behaving as histone deacetylase inhibitors, and examined for their influence on vascular cognitive impairment (VCI), which correlated with dementia. The results revealed that (E)-3-(4-(((3-(3-chloro-10,11-dihydro-5H-dibenzo [b,f]azepin-5-yl)propyl)amino)methyl)phenyl)-N-hydroxy-acrylamide (13) increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy in in vivo study. It is also able to increase the level of histone acetylation (H3K14 or H4K5) in the cortex and hippocampus of chronic cerebral hypoperfusion (CCH) mice; as a result, it could be a potential HDAC inhibitor for the treatment of vascular cognitive impairment.
KW - Histone deacetylase inhibitors
KW - Neurodegenerative disease
KW - Vascular cognitive impairment
UR - http://www.scopus.com/inward/record.url?scp=85076133362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076133362&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2019.111915
DO - 10.1016/j.ejmech.2019.111915
M3 - Article
AN - SCOPUS:85076133362
SN - 0223-5234
VL - 187
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
M1 - 111915
ER -